In a feasibility trial of a polymer-free dual drug-eluting stent, Beijing researchers found no deaths, MI or stent thrombosis four months post-procedure and only three target lesion failure events linked to repeat revascularization at 18 months. In the study, reported in Catheterization and Cardiovascular Interventions, researchers placed the Bicare stent, a polymer-free nanotechnology stent that releases sirolimus and probucol, in 32 patients with a single de novo native coronary stenosis.

Related Summaries